# Tailored Therapy for Clarithromycin-Resistant H. Pylori

> **NCT03431688** · NA · COMPLETED · sponsor: **Kangdong Sacred Heart Hospital** · enrollment: 782 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** PAM
- **DRUG:** PBMT

## Key facts

- **NCT ID:** NCT03431688
- **Lead sponsor:** Kangdong Sacred Heart Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2020-10-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 782 (ACTUAL)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03431688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03431688, "Tailored Therapy for Clarithromycin-Resistant H. Pylori". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03431688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*